HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatal Pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis.

AuthorsMaria K Stilling-Vinther, Bhuvanapriya S Pedersen
JournalActa ophthalmologica (Acta Ophthalmol) Vol. 90 Issue 2 Pg. e154-5 (Mar 2012) ISSN: 1755-3768 [Electronic] England
PMID21649871 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • DNA, Fungal
  • Immunosuppressive Agents
  • Rituximab
  • Methylprednisolone
Topics
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Bronchoalveolar Lavage Fluid (microbiology)
  • DNA, Fungal (genetics)
  • Drug Therapy, Combination
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Methylprednisolone (administration & dosage)
  • Opportunistic Infections (complications, drug therapy, microbiology)
  • Pneumocystis carinii (isolation & purification)
  • Pneumonia, Pneumocystis (complications, drug therapy, microbiology)
  • Polymerase Chain Reaction
  • Rituximab
  • Scleritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: